REQUEST A DEMO
Total
USD $0.00
Search more companies

Naturewise Biotech & Medicals Corporatio (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Naturewise Biotech & Medicals Corporatio Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

NatureWise Biotech & Medicals Corp. was established in Dec. 2000, jointly by Kangyang Pharmacy and Singapore Weiyong Biotech, to promote Chinese medicine clinical research, drug certificate application and drug production & sales. The main business is the R & D of lipid-lowering medicine and health food, mainly for domestic market. The main products include Life Mevacor One, Zhiyouquan, Women's Expensive, Fengyouquan, Huiyouquan and children Huiyouquan.

Headquarters
6F., No.36, Sec. 3, Bade Rd., Songshan Dist
Taipei City; Taipei City;

Contact Details: Purchase the Naturewise Biotech & Medicals Corporatio report to view the information.

Website: http://www.naturewise.com.tw

Basic Information
Total Employees:
Purchase the Naturewise Biotech & Medicals Corporatio report to view the information.
Outstanding Shares:
Purchase the Naturewise Biotech & Medicals Corporatio report to view the information.
Financial Auditors:
Purchase the Naturewise Biotech & Medicals Corporatio report to view the information.
Incorporation Date:
December 29, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
6.87%
Purchase this report to view the information.
5.95%
Purchase this report to view the information.
5.33%
Purchase this report to view the information.
2.15%
Purchase this report to view the information.
0.15%
Subsidiaries
彥臣生物科技(東莞)有限公司 (China)
100%
御華生醫股份有限公司
100%
澄杏醫藥有限公司
100%
Company Performance
Financial values in the chart are available after Naturewise Biotech & Medicals Corporatio report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
97.09%
Total operating revenue
97.25%
Operating profit (EBIT)
538.56%
EBITDA
27.8%
Net Profit (Loss) for the Period
114.92%
Total assets
2.23%
Total equity
2.99%
Operating Profit Margin (ROS)
2.9%
Net Profit Margin
0.46%
Return on Equity (ROE)
0.6%
Quick Ratio
0.47%
Cash Ratio
0.71%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?